初次全膝关节置换术后阿司匹林血栓预防与其他药物相比与早期假体周围关节感染率较低相关
该回顾性研究纳入2013至2019年单中心11,547例初次全膝关节置换患者,比较阿司匹林与非阿司匹林血栓预防对术后90天内早期假体周围关节感染的影响。阿司匹林组早期感染率为0.3%,非阿司匹林组为0.8%(P<.001);多因素回归显示阿司匹林组感染风险显著更低(OR=0.51,95%CI 0.29-0.89,P=.019)。作者认为阿司匹林可作为医学上合适患者的金标准血栓预防选择。
要点
- 阿司匹林组早期假体周围关节感染率为0.3%,非阿司匹林组为0.8%,差异有统计学意义(P<.001)。
- 调整年龄、体质指数、性别和Charlson合并症指数后,阿司匹林组感染风险更低(OR=0.51,95%CI 0.29-0.89,P=.019)。
- 作者建议关节外科医生将阿司匹林视为医学上合适患者的金标准血栓预防。
核心结论
- 初次全膝关节置换术后使用阿司匹林进行血栓预防与较低的早期假体周围关节感染率独立相关。
研究设计与样本
- 回顾性研究,纳入2013至2019年单中心学术骨科医院的11,547例初次全膝关节置换患者,证据等级为治疗性III级。
主要发现
- 术后90天内根据肌肉骨骼感染学会标准诊断早期假体周围关节感染59例(0.5%)。
- 阿司匹林组早期假体周围关节感染率为0.3%,非阿司匹林组为0.8%,差异有统计学意义(P<.001)。
- 多因素logistic回归调整年龄、体质指数、性别和Charlson合并症指数后,阿司匹林组假体周围关节感染风险显著更低(OR=0.51,95%CI 0.29-0.89,P=.019)。
关键数值与推荐
- 早期假体周围关节感染的判定采用肌肉骨骼感染学会标准,时间窗为术后90天。
- 统计学显著性设定为P<.05。
临床怎么用
- 作者认为,关节外科医生应考虑将阿司匹林作为所有医学上合适患者的金标准血栓预防。
- 作者建议,在考虑使用非阿司匹林血栓预防时,应仔细权衡假体周围关节感染的疾病负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients undergoing total knee arthroplasty (TKA) are at increased risk of venous thromboembolism (VTE). Aspirin has been shown to be effective at reducing rates of VTE. In select patients, more potent thromboprophylaxis is indicated, which has been associated with increased rates of bleeding and wound complications. This study aimed to evaluate the effect of thromboprophylaxis choice on the rates of early prosthetic joint infection (PJI) following TKA. METHODS: A review of 11,547 primary TKA patients from 2013 to 2019 at a single academic orthopaedic hospital was conducted. The primary outcome measure was PJI within 90 days of surgery as measured by Musculoskeletal Infection Society criteria. There were 59 (0.5%) patients diagnosed with early PJI. Chi-square and Welch-2 sample t-tests were used to determine statistically significant relationships between thromboprophylaxis and demographic variables. Significance was set at P < .05. Multivariate logistic regression adjusted for age, body mass index, sex, and Charlson comorbidity index was performed to identify and control for independent risk factors for early PJI. RESULTS: There was a statistically significant difference in the rates of early PJI between the aspirin and non-aspirin group (0.3 versus 0.8%, P < .001). Multivariate logistic regressions revealed that patients given aspirin thromboprophylaxis had significantly lower odds of PJI (odds ratios = 0.51, 95% confidence interval = 0.29-0.89, P = .019) compared to non-aspirin patients. CONCLUSION: The use of aspirin thromboprophylaxis following primary TKA is independently associated with a lower rate of early PJIs. Arthroplasty surgeons should consider aspirin as the gold standard thromboprophylaxis in all patients in which it is deemed medically appropriate and should carefully weigh the morbidity of PJI in patients when non-aspirin thromboprophylaxis is considered. LEVEL OF EVIDENCE: Retrospective, Therapeutic Level III.
引用
- Anil U, Kirschner N, Teo GM, et al. Aspirin Thromboprophylaxis Following Primary Total Knee Arthroplasty Is Associated With a Lower Rate of Early Prosthetic Joint Infection Compared With Other Agents. J Arthroplasty. 2023. PMID: 36828050. doi:10.1016/j.arth.2023.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。